Baseline characteristics of BRVO and CRVO exposed
| BRVO exposed | CRVO exposed | |
| (n=3683) | (n=2846) | |
| Sex | ||
| Men | 1763 (47.9) | 1534 (53.9) |
| Women | 1920 (52.1) | 1312 (46.1) |
| Age at index date (years) | 54.0 (45.8–61.8) | 56.9 (48.0–64.3) |
| Age at RVO diagnosis (years) | 71.1 (62.6–78.4) | 73.0 (64.1–80.5) |
| No of incident RVO diagnoses, mean no. per year | ||
| 1998–2010 | 32 | 41 |
| 2011–2018 | 409 | 289 |
| Charlson Comorbidity Index score | ||
| 0 (low) | 3421 (92.9) | 2614 (91.8) |
| 1 | 134 (3.6) | 108 (3.8) |
| 2 | 108 (2.9) | 103 (3.6) |
| >3 (high) | 20 (0.5) | 21 (0.7) |
| Comorbid conditions | ||
| Arterial hypertension | 2438 (66.2) | 1867 (65.6) |
| Dyslipidaemia | 1980 (53.8) | 1476 (51.9) |
| Diabetes | 636 (17.3) | 500 (17.6) |
| Smoking-related disorders | 280 (7.6) | 271 (9.5) |
Data presented as median (25%–75% percentile) for continuous variables and count (%) for categorical variables.
BRVO, branch retinal vein occlusion; CRVO, central retinal vein occlusion.